10x Genomics Inc. (TXG)
undefined
undefined%
At close: undefined
16.01
0.50%
After-hours Jan 06, 2025, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -255.10M -166.00M -58.22M -542.73M -31.25M -112.48M -18.76M
Depreciation & Amortization 43.62M 33.01M 28.25M 19.02M 7.07M 3.90M 4.30M
Stock-Based Compensation 166.95M 136.85M 95.96M 48.63M 13.33M 2.66M 1.66M
Other Working Capital 26.10M -5.13M -34.36M -10.16M 51.85M 43.91M 6.04M
Other Non-Cash Items 11.99M 1.96M 79.00K 306.02M 101.00K 1.25M 149.00K
Deferred Income Tax n/a n/a n/a 1.55M 614.00K 251.00K n/a
Change in Working Capital 17.34M -39.42M -87.44M -50.38M 44.76M 28.02M 1.95M
Operating Cash Flow -15.20M -33.61M -21.37M -217.90M 34.63M -76.41M -10.70M
Capital Expenditures -49.52M -131.66M -101.28M -38.39M -42.77M -6.71M -3.76M
Acquisitions n/a -4.00M -5.45M n/a n/a n/a n/a
Purchase of Investments n/a -282.87M n/a n/a n/a n/a n/a
Sales Maturities Of Investments 183.02M 67.64M n/a n/a n/a n/a n/a
Other Investing Acitivies -923.00K -215.23M n/a -1.73M -25.00K -425.00K n/a
Investing Cash Flow 133.49M -350.89M -106.73M -38.39M -42.77M -6.71M -3.76M
Debt Repayment n/a n/a n/a -37.10M n/a 18.74M -393.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a -80.00K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 13.67M 15.82M 35.30M 23.74M 3.77M 86.63M 21.06M
Financial Cash Flow 13.67M 15.82M 35.30M 468.91M 414.59M 105.37M 20.58M
Net Cash Flow 131.93M -368.72M -92.57M 212.15M 406.40M 22.23M 6.11M
Free Cash Flow -64.72M -165.27M -122.65M -256.29M -8.14M -83.12M -14.46M